Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
MIST PE Ratio & Valuation, Is MIST Overvalued
Milestone Pharmaceuticals Inc (MIST) is currently in the “Fair zone” according to its forward PS ratio of 5.09, which is considered fair compared to its five-year average. Despite this, its current Price-to-Book ratio is significantly higher than its 3-year and 5-year averages, while its Forward Free Cash Flow yield is lower. The company’s P/S ratio is notably above the industry average, raising questions about the sustainability of its premium.